Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 14, 2009; 15(18): 2270-2276
Published online May 14, 2009. doi: 10.3748/wjg.15.2270
Figure 3
Figure 3 Overall 5-year survival curve of colorectal adenocarcinoma patients with TSPAN1 negative (-) and TSPAN1 positive (+, ++, +++) for the entire cohort (P = 0. 001) was estimated by Kaplan-Meier test. Survival rate in TSPAN1 expression groups (++, +++) were obviously lower than that of weak expression (+) or negative (-) group, respectively (P < 0.05). There was no significant difference of survival rates between TSPAN1 negative group (-) and TSPAN1 weak expression group (+).